BACE1 and Alzheimer disease: The study of cKO mice in parallel with pharmacological BACE inhibition in animal models will facilitate the understanding of the mechanism(s) underlying the cognitive worsening observed in AD patients treated with BACE inhibitors, distinguish between BACE1-dependent phenotypes and off-target effects and finally improve drug dosing for future clinical applications.